Literature DB >> 1757125

Generation of xenopsin-related peptides from tissue precursors by media conditioned by endotoxin-stimulated rat peritoneal macrophages.

D E Cochrane1, R E Carraway, W Boucher.   

Abstract

Incubation of media conditioned by endotoxin-stimulated rat peritoneal macrophages generates immunoreactive xenopsin (iXP) when incubated with acid extracts of various tissues of the rat. The generation of iXP, as measured by specific radioimmunoassay and confirmed by HPLC analysis, increased as the length of the incubation period increased and was inhibited by pepstatin, prior boiling of the conditioned media, or by omitting either the tissue extract or the conditioned media. The pH optimum for the generation of iXP was 3.0. The generated iXP showed biological activity in that stimulated histamine secretion from isolated rat mast cells and this secretory response was prevented by metabolically poisoning the cells. In addition, the generated iXP stimulated contraction of the isolated guinea pig ileum. In this regard, it was similar to neurotensin (NT). Tissue precursor levels for iXP, as measured by this system of generation, were highest in kidney, liver, and skin and lowest in skeletal muscle and plasma. These results suggest to us that during the inflammatory response, the NT-related peptide, xenopsin, can be generated from tissue precursor(s) by enzymes secreted by invading macrophages. The generated XP may then affect the participating cells of inflammation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757125     DOI: 10.1007/bf00917354

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Isolation and structures of xenopsin-related peptides from rat stomach, liver and brain.

Authors:  R E Carraway; S P Mitra; K Muraki
Journal:  Regul Pept       Date:  1990-07-30

2.  The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin.

Authors:  M H Mogard; R Kobayashi; C F Chen; T D Lee; J R Reeve; J E Shively; J H Walsh
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

3.  Cathepsin D activity in human peripheral blood mononuclear leukocytes.

Authors:  C T Bever; K D Morgan; J N Whitaker
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

4.  [Comparative studies of xenopsin and neurotensin on some biological activities (author's transl)].

Authors:  K Araki; S Tachibana; Y Kato; T Tajima
Journal:  Yakugaku Zasshi       Date:  1979-05       Impact factor: 0.302

5.  Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study.

Authors:  A R Poole; R M Hembry; J T Dingle; I Pinder; E F Ring; J Cosh
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

6.  Comparison studies of neurotensin and xenopsin upon pancreatic secretion in the dog [proceedings].

Authors:  T Ishida; K Kawamura; A Goto; Y Nishina; J Takahara
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

7.  Xenopsin stimulates exocrine pancreatic secretion in the dog.

Authors:  G E Feurle; I Baća; W Knauf; A Schwab; T Araki; R Carraway
Journal:  Experientia       Date:  1982-06-15

8.  Amphibian neurotensin (NT) is not xenopsin (XP): dual presence of NT-like and XP-like peptides in various amphibia.

Authors:  R Carraway; S E Ruane; G E Feurle; S Taylor
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

9.  Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48-80 or the ionophores A-23187 and X-537A.

Authors:  D E Cochrane; W W Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

10.  Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s).

Authors:  R E Carraway; S P Mitra; D E Cochrane
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.